Can Lyme Disease Cause Joint Pain?

Lyme disease is a common illness spread by ticks, caused by the bacterium Borrelia burgdorferi. Found across the United States and Europe, the infection can affect multiple organ systems, but joint pain is one of its most frequent manifestations. Early symptoms often include a characteristic skin rash. If the infection goes untreated, the bacteria can spread throughout the body, leading to inflammation and discomfort in the joints.

The Direct Connection Lyme Arthritis

Lyme disease causes joint pain through a specific condition known as Lyme Arthritis. This is the most common manifestation of late-stage or untreated Lyme disease in the United States. Lyme Arthritis is a form of inflammatory arthritis, not general body aches. It involves a severe, localized immune response to the Borrelia bacteria present within the joint space.

Typical Symptoms and Progression

Lyme Arthritis presents a characteristic pattern of symptoms. It typically involves one or a few large joints, most often the knee. Although the joint is noticeably swollen, warm, and stiff, the pain level is often less severe than the visible swelling suggests.

The presentation is usually episodic, meaning swelling and pain come on suddenly and resolve naturally after several weeks or months. These episodes can recur if the infection remains untreated. Lyme Arthritis is a late-stage symptom, appearing weeks to months, or up to two years, after the initial tick bite and rash (Erythema migrans) have faded.

In a smaller percentage of patients, the episodes of joint inflammation can become persistent, progressing into a chronic form of arthritis. The inflammation most commonly affects large joints, such as the shoulder, ankle, elbow, or wrist. It is usually asymmetric, meaning it does not affect the same joint on both sides of the body simultaneously.

Understanding the Cause of Joint Inflammation

Joint inflammation is caused by Borrelia burgdorferi invading the synovium, the lining of the joint capsule. Once inside, the bacteria trigger a massive immune response. The immune system releases inflammatory molecules and sends immune cells into the joint space to eradicate the pathogen.

This heightened inflammatory response, while aimed at the bacteria, inadvertently leads to damage and inflammation of the host’s joint tissues. In some cases, the immune response continues even after the bacteria have been successfully cleared by antibiotics, a phenomenon thought to involve residual bacterial components or an immune-mediated mechanism. This intense, local inflammation can cause the joint lining to thicken and may eventually lead to the degradation of cartilage and bone if left untreated. Genetic factors also play a role, as certain genetic markers are associated with an increased risk of developing persistent arthritis.

Diagnosis and Treatment Approaches

Diagnosing Lyme Arthritis begins with a thorough physical examination, focusing on the affected joints, combined with a detailed patient history to assess for potential tick exposure in endemic areas. Laboratory testing is then used to confirm the presence of antibodies against Borrelia burgdorferi in the blood. This standard diagnostic approach for late-stage Lyme disease involves a two-tiered process: an Enzyme-Linked Immunosorbent Assay (ELISA) screening test, followed by the more specific Western blot test for confirmation.

If the diagnosis is uncertain, a physician may aspirate fluid directly from the swollen joint. This synovial fluid can be tested using Polymerase Chain Reaction (PCR) technology to detect the bacteria’s DNA, confirming an active infection in the joint. Since Lyme Arthritis is a bacterial infection, treatment primarily involves antibiotics.

Treatment

An initial episode is usually treated with a four-week course of oral antibiotics, such as doxycycline or amoxicillin. Patients who do not respond adequately may require a second course of oral antibiotics or a switch to intravenous antibiotics, such as ceftriaxone. A small number of patients experience persistent joint inflammation even after successful antibiotic treatment, which is typically residual inflammation rather than an active infection. This persistent pain is managed with anti-inflammatory agents or other rheumatologic treatments, sometimes requiring referral to a rheumatologist.